Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma-Reply. [electronic resource]

By: Contributor(s): Producer: 20190924Description: 1136-1137 p. digitalISSN:
  • 2374-2445
Subject(s): Online resources: In: JAMA oncology vol. 4
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Comment

There are no comments on this title.

to post a comment.